Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crocodex: Dexamethasone Intra-Erythrocyte Therapy in IBD
NCT01171807Phase 2Completed
- Sponsor
- IRulya Therapeutics
- Start
- Jul 2003
- Primary completion
- May 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone sodium phosphate in Crohn's disease, ulcerative colitis (UC), sponsored by IRulya Therapeutics. Started Jul 2003; status: completed.
02
Drugs
dexamethasone sodium phosphate
03
Conditions
Crohn's diseaseulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01171807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01171807.